Now showing items 1-1 of 1

    • Safety of once-or twice-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation: A NOAC-TR study 

      Emren, S.V. and Zoghi, M. and Berilgen, R. and Özdemir, İ.H. and Çelik, O. and Çetin, N. and Enhoş, A. and Köseoğlu, C. and Akyüz, A. and Doğan, V. and Levent, F. and Dereli, Y. and Doğan, T. and Başaran, Ö. and Karaca, I. and Karaca, Ö. and Otlu, Y.Ö. and Özmen, Ç. and Coşar, S. and Sümerkan, M. and Gürsul, E. and İnci, S. and Onrat, E. and Ergene, O. (Association of Basic Medical Sciences of FBIH, 2018)
      Once-daily dosing of non-vitamin K antagonist oral anticoagulants (NOACs) may increase patient adherence to treatment but may also be associated with a higher risk of bleeding. In this study, we investigated the adherence ...